Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MEDIMMUNE INC (MEDI)
|
Add to portfolio |
|
|
|
| Price: |
$0.91
| | Metrics |
| OS: |
255.5
|
M
| |
11
|
% ROE
|
| Market cap: |
$232
|
M
| |
4
|
% ROIC
|
|
Net cash:
|
$440
|
M
| |
$1.72
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$221
|
M
| |
-0.9
|
x EV/EBITDA
|
|
EBIT
|
$103
|
M
| |
-2.0
|
x EV/EBIT
|
| EPS |
$0.66
| |
1.4
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 |
| Revenues | 1,276.8 | 1,243.9 | 1,141.1 | 1,054.4 | 852.7 | 620.7 | 540.5 |
| Revenue growth | 2.6% | 9.0% | 8.2% | 23.7% | 37.4% | 14.8% | |
| Cost of goods sold | 327.7 | 336.7 | 366.4 | 289.8 | 201.8 | 138.7 | 127.3 |
| Gross profit | 949.1 | 907.2 | 774.7 | 764.6 | 650.9 | 482.0 | 413.2 |
| Gross margin | 74.3% | 72.9% | 67.9% | 72.5% | 76.3% | 77.7% | 76.4% |
| Selling, general and administrative | 541.2 | 498.4 | 400.2 | 340.9 | 299.6 | 196.8 | 157.3 |
| EBIT | -57.0 | 11.7 | 38.6 | 241.3 | 103.3 | 192.5 | 180.3 |
| EBIT margin | -4.5% | 0.9% | 3.4% | 22.9% | 12.1% | 31.0% | 33.4% |
| Pre-tax income | 74.6 | 7.5 | -9.2 | 291.2 | -1,049.8 | 228.5 | 209.4 |
| Income taxes | 25.9 | 24.1 | -5.4 | 108.0 | 48.2 | 79.5 | 64.4 |
| Tax rate | 34.7% | 321.3% | 58.7% | 37.1% | | 34.8% | 30.8% |
| Net income | 48.7 | -16.6 | -3.8 | 183.2 | -1,098.0 | 149.0 | 111.2 |
| Net margin | 3.8% | -1.3% | -0.3% | 17.4% | -128.8% | 24.0% | 20.6% |
| |
| Diluted EPS | $0.20 | ($0.07) | ($15,285.60) | $0.71 | ($4.40) | $0.68 | $0.53 |
| Shares outstanding (diluted) | 246.3 | 246.9 | 0.0 | 257.2 | 249.6 | 220.1 | 209.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|